| Xiaomin, Niu |
NCT04977791: Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer |
|
|
| Recruiting | N/A | 250 | RoW | Anti-PD-1/PD-L1 monoclonal antibody, Immune checkpoint inhibitor | Shanghai Chest Hospital | Non-Small Cell Lung Cancer | 12/26 | 12/28 | | |
| Niu, Xiaomin |
| Recruiting | N/A | 500 | RoW | immunotherapy, Targeted Therapy Agent | Shanghai Chest Hospital | Lung Neoplasms, Psychological Distress, Prognosis Factors, Lifestyle, Healthy, IMMUNOTHERAPY, Targeted Molecular Therapy | 12/27 | 12/28 | | |
NCT04722406: Tumor Growth Rate (TGR) Predicts Clinical Outcomes for Advanced Non-small Cell Lung Cancer Undergoing Immunotherapy. |
|
|
| Recruiting | N/A | 350 | RoW | This item is not applicable to our observational study. | Sun Yat-sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Shanghai Chest Hospital | Non-Small Cell Lung Cancer | 07/21 | 08/21 | | |
NCT06730503: Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer |
|
|
| Recruiting | N/A | 250 | RoW | Immune checkpoint inhibitor | Shanghai Chest Hospital | Non Small Cell Lung Cancer | 10/27 | 10/28 | | |
NCT05945745: Molecular Analysis and Treatment Options of SCLC |
|
|
| Recruiting | N/A | 500 | RoW | Chemotherapy, immunotherapy, targeted therapy | Shanghai Chest Hospital | Small-cell Lung Cancer, Small Cell Lung Cancer, Combined Type, Small Cell Lung Carcinoma, Small Cell Lung Cancer Extensive Stage, Small Cell Lung Cancer Limited Stage | 12/27 | 12/28 | | |
NCT04636047: NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy |
|
|
| Recruiting | N/A | 450 | RoW | The method of gene mutation detection | Shanghai Chest Hospital | Lung Cancer | 02/23 | 08/23 | | |
NCT05667948: Molecular Analysis and Treatment Options of Thymic Malignancies |
|
|
| Recruiting | N/A | 500 | RoW | Chemotherapy, targeted therapy, immunotherapy | Shanghai Chest Hospital | Thymic Epithelial Tumor, Thymic Carcinoma, Thymic Cancer | 12/25 | 12/26 | | |
NCT05701787: Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations |
|
|
| Recruiting | N/A | 500 | RoW | | Shanghai Chest Hospital | NSCLC, NSCLC Stage IV, NSCLC, Recurrent | 12/28 | 12/29 | | |
